ID
45470
Description
Principal Investigator: Jay Shendure, PhD, University of Washington, Seattle, WA, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000500 The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma collected during the first half of gestation.
Link
Keywords
Versions (2)
- 11/2/22 11/2/22 - Tabea Kampen
- 12/13/22 12/13/22 - Kristina Keller
Copyright Holder
Jay Shendure, PhD, University of Washington, Seattle, WA, USA
Uploaded on
December 13, 2022
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000500 Non-Invasive Whole Genome Sequencing of a Human Fetus
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
C1320396 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0086582 (UMLS CUI [1,4])
C0444245 (UMLS CUI [2,1])
C0015671 (UMLS CUI [2,2])
C0026591 (UMLS CUI [2,3])
C0008059 (UMLS CUI [3,1])
C0443281 (UMLS CUI [3,2])
C0444245 (UMLS CUI [3,3])